Help is at hand for migraine sufferers thanks to a new trial at RPA hospital.
MIGRAINE sufferers are being invited to take part in a trial aimed at preventing debilitating attacks.
Volunteers will be trialling the effectiveness of new multi-pill blood pressure or cholesterol lowering drugs.
Currently just 20 per cent of people who suffer from migraines take any form of preventative medicine due to widespread side effects of available treatments. Researchers hope the new treatments will not only prove effective at preventing migraines and the frequency, they may also reduce the unwanted side effects.
Dr Cheryl Carcel, Neurologist and Research Fellow at The George Institute, says migraine affects millions of people in Australia.
"We know that sufferers would love to be able to reduce the amount of attacks they have each month or of course, prevent them altogether," Dr Carcel said.
"But at the moment many of the pills on the market produce weight gain and fatigue so people avoid them."
Migraine sufferer Tanya Walker, 50, has just taken part in the trial and revealed the number of her attacks hasdropped by about half.
"It took away the daily fear I had about developing a migraine," she said.
Tanya, who has been having migraines since the age of 14, says she hopes the trial will help other migraine sufferers including her own daughter.
The trial will be taking place at RPA Hospital in Camperdown.
Participants must be aged 18-65, have two to 14 migraines a month for at least 12 months, and must have started experiencing migraines before they turned 50. They must also be willing to take medication for 12 weeks and be able to visit RPA every four weeks for 20 weeks.
Call 1800 397 371 for further information.